Comments
Loading...
InMed Pharmaceuticals (NASDAQ:INM) Stock, Earnings Estimates, EPS, And Revenue
InMed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-2.710
Quarterly Revenue
$1.3M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$5M
Analyze the earnings history of InMed Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
InMed Pharmaceuticals (INM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2022 | 2022-09-23 | $-12.92 | $-5.50 | -134.9 % |
| Dec 2021 | 2022-02-14 | $-7.75 | $-5.75 | -34.8 % |
InMed Pharmaceuticals (INM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-13 | $1.24M | $1.39M | -10.8 % |
| Jun 2022 | 2022-09-23 | $514.76K | $750.00K | -31.4 % |
| Dec 2021 | 2022-02-14 | $265.09K | $120.00K | 120.9 % |
FAQ
When is InMed Pharmaceuticals (NASDAQ:INM) reporting earnings?
InMed Pharmaceuticals (INM) is scheduled to report earnings on February 11, 2025. The last reported earnings were for reported on November 14, 2024 for Q1.
What were the latest earnings per share (EPS) for InMed Pharmaceuticals (NASDAQ:INM)?
The Actual EPS was $-2.71, which missed the estimate of $0.00.
What were InMed Pharmaceuticals’s (NASDAQ:INM) revenues?
The Actual Revenue was $1.3M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.